Prosecution Insights
Last updated: October 25, 2026

Rothwell, Figg, Ernst and Manbeck, P.C.

Technology areas: Biotechnology & Pharmaceuticals • Networking & Security

284 pending office actions • 97 clients • 271 examiners • 178 art units • 0 of 284 (0%) have an AI response strategy ready

Analysis

ROTHWELL, FIGG, ERNST & MANBECK, P.C. works in Biotechnology & Pharmaceuticals, with 14,002 career applications and 277 pending office actions. The profile therefore reflects both a substantial historical application record and an active pending docket.

Its resolved allowance rate is 82.87%, and the average is 3.43 office actions per allowance. These figures suggest that allowance outcomes should be considered together with the amount of examination activity associated with each allowance. For applicants in this technology area, the pending-action total also provides context for assessing current prosecution demand.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=14002 apps, methodology: how we score firms)

82.9%
Allowance Rate
n=14002
+0.61σ
Allowance Rate (norm)
n=14002
3.4
OAs to Allowance
n=9268
-0.08σ
OAs to Allow (norm)
n=9268
1056 days
Time to Allowance
n=9268
+9.8pp
Interview Lift
n=14002
25.7%
RCE Rate
n=14002
2.0%
Appeal Rate
n=14002

Rejection Performance (% of received rejections ultimately overcome)

79.5%
§101 Overcome
n=1110
79.1%
§102 Overcome
n=3625
80.8%
§103 Overcome
n=6168
81.9%
§112 Overcome
n=4323

Specialization & Scale

A61K, H04W, H04L
Top CPC Subclasses
17%
Top-3 CPC Share
n=14002
16
Practitioners
n=14002
875.1
Apps / Practitioner
n=14002

Portfolio Summary

284
Total Pending OAs
191
Non-Final OAs
77
Final Rejections
16
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 59 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

25
Overdue
2
Due this week
22
Due this month
7
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 59 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (25)Due ≤ 7 days (2)Due ≤ 30 days (22)Due ≤ 60 days (7)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

151
Hard (53%)
115
Medium (40%)
17
Easy (6%)
1
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (1%)
§101 + other40 (14%)
§103 only83 (29%)
§102 only10 (4%)
§112 only13 (5%)
Double-patenting only4 (1%)
Double-patenting + other22 (8%)
Multi-statute (no §101)109 (38%)
No statute on record1 (0%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

132
Life Sciences
46% of docket
80
Information Tech
28% of docket
25
Communications
9% of docket
10
Semiconductors
4% of docket
32
Mechanical / Eng
11% of docket
5
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

2,840 h
Manual time on pending OAs
568 h
Time saved (low, 20%)
994 h
Time saved (mid, 35%)
24.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SOROUSH, LAYLA 3 40.5% +43.4%
KIM, ANDREW CHANUL 3 55.8% +11.6%
HILAIRE, CLIFFORD 2 71.8% +14.9%
TORRENTE, RICHARD T 2 69.9% +13.8%
AGGARWAL, SAHIL CHANDER 2 66.7% +0.0%
AL SAMAHI, SANAA SHAKER ABED 2 61.5% +52.4%
MOREAU, NASHARA LOUISE 2 66.7% -80.0%
RIETH, STEPHEN EDWARD 2 45.5% +33.7%
PECKHAM, RICHARD GRANT 2 68.1% +36.1%
SCHEIBEL, ROBERT C 2 80.7% +15.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18288485 METHODS FOR INTER-NODE COORDINATION FOR RAN ENERGY SAVING SCHEIBEL, ROBERT C —

Hard Cases (151)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17891418 SYSTEMS AND METHODS FOR THE PRODUCTION OF HYDROGEN AND CARBON TAI, XIUYU 120d overdue
18021762 LONG HEAT PATH SUPPORT STRUCTURE KING, BRIAN M 111d overdue
18033947 METHOD FOR PRODUCING A SOLID INGREDIENT, SOLID INGREDIENT WHICH CAN BE OBTAINED BY IMPLEMENTING SAID PRODUCTION METHOD, AND USES OF SAID INGREDIENT SILVERMAN, JANICE Y 59d overdue
17425039 MICROCARRIER FOR CELL CULTURE, METHOD FOR PRODUCING THE SAME, AND CELL CULTURE METHOD USING THE SAME CLARKE, TRENT R 53d overdue
17908791 MASTER CELL GROUP (MCG) FAILURE AND RADIO LINK FAILURE (RLF) REPORTING KIM, ANDREW CHANUL 44d overdue
18277448 AVOIDING LOSING NETWORK ACCESS DUE TO LACK OF NAVIGATION SYSTEM COVERAGE SHIVERS, ASHLEY L 32d overdue
18723705 DEVICE FOR PROCESSING INTRACARDIAC SIGNALS D ABREU, MICHAEL JOSEPH 31d overdue
17788868 CELL CULTURE SUBSTRATE AND MANUFACTURING METHOD THEREOF TAKENAKA, RISA 19d overdue

Interview Candidates (18)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17908791 MASTER CELL GROUP (MCG) FAILURE AND RADIO LINK FAILURE (RLF) REPORTING KIM, ANDREW CHANUL 44d overdue
17778894 SCHEDULING FOR MULTI-TRANSMISSION RECEPTION POINT TRANSMISSION WITH DYNAMIC ON-OFF SWITCHING KIM, ANDREW CHANUL 9d
18552883 EXTENDED DISCONTINUOUS RECEPTION DIFFERENTIATION FOR NEW RADIO (NR) SCHEIBEL, ROBERT C 21d
18557775 METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR PECKHAM, RICHARD GRANT 22d
18695573 DETECTION OF POORLY DEPLOYED FWA TERMINALS AL SAMAHI, SANAA SHAKER ABED 46d
19473702 POSITION DEPENDENT FILTERING HILAIRE, CLIFFORD —
19143600 REDUCING COMPLEXITY OF VIDEO ENCODING AND DECODING HILAIRE, CLIFFORD —
19214835 DECODING BASED ON BI-DIRECTIONAL PICTURE CONDITION TORRENTE, RICHARD T —

Client Portfolio (97 clients)

View all 97 →

Top Art Units

Art UnitApps
37916
16226
24785
16935
16235
17665
24714
17924
16263
16143

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19559185 DISPLAY APPARATUS AND METHOD OF CONTROLLING THE SAME LX SEMICON CO., LTD. MANDEVILLE, JASON M 2623 §102 Non-Final OA — Pending Mar 06, 2026
19479234 EDGE DIMMING CONTROL DEVICE AND METHOD LX SEMICON CO., LTD. NGUYEN, JIMMY H 2626 §101§103§112 Non-Final OA — Pending Oct 27, 2025
19477746 A HARD HAT WITH AN INTEGRATED ELECTRONIC SUBSYSTEM Xyz Reality Limited MANGINE, HEATHER N 3732 §112 Non-Final OA — Pending Oct 22, 2025
19475801 CREATING A LARGE SCALE HEAD-RELATED FILTER DATABASE Telefonaktiebolaget Lm Ericsson (Publ) GURMU, MULUEMEBET 2163 §101§103 Non-Final OA — Pending Oct 16, 2025
19473702 POSITION DEPENDENT FILTERING Telefonaktiebolaget Lm Ericsson (Publ) HILAIRE, CLIFFORD 2488 §101§102§103§112 Non-Final OA — Pending Oct 08, 2025
19341379 LOW-SORBING GLYBURIDE FORMULATION AND METHODS Remedy Pharmaceuticals, Inc. SHIM, DAVID M. 1626 §103 Final Rejection 75d Pending Sep 26, 2025
19331031 GAS ENGINE Ihi Power Systems Co., Ltd. VILAKAZI, SIZO BINDA 3747 §102§103 Non-Final OA — Pending Sep 17, 2025
19325045 DATA DRIVING DEVICE AND DATA PROCESSING DEVICE OPERATING IN LOW POWER MODE Silicon Works Co., Ltd. LEE, NICHOLAS J 2624 §102§103 Non-Final OA — Pending Sep 10, 2025
19280853 COMBUSTION SYSTEM USING AMMONIA AS FUEL Ihi Corporation MALATEK, KATHERYN A 3741 §103§112 Non-Final OA — Pending Jul 25, 2025
19143600 REDUCING COMPLEXITY OF VIDEO ENCODING AND DECODING Telefonaktiebolaget Lm Ericsson (Publ) HILAIRE, CLIFFORD 2488 §101§103 Non-Final OA — Pending Jun 26, 2025
19233267 HYBRID SYSTEM FOR PROCESSING CONTAINERS David Melrose Design Limited FRY, PATRICK B 3731 §102Other Non-Final OA 14d Pending Jun 10, 2025
19232338 IMPLANT FINDER Senseonics, Incorporated LY, TOMMY TAI 3797 §103§112 Non-Final OA — Pending Jun 09, 2025
19232605 CONTAINER WITH DYNAMIC BASE Co2Pac Limited CASTELLANO, STEPHEN J 3733 §102§103§112 Non-Final OA — Pending Jun 09, 2025
19226882 DEVICES AND METHODS FOR PROVISION OF RESOURCE REPRESENTATIONS Telefonaktiebolaget Lm Ericsson (Publ) SHITAYEWOLDETSADI, BERHANU 2455 §103 Non-Final OA — Pending Jun 03, 2025
19214835 DECODING BASED ON BI-DIRECTIONAL PICTURE CONDITION Telefonaktiebolaget Lm Ericsson (Publ) TORRENTE, RICHARD T 2485 §102§103 Final Rejection — Pending May 21, 2025
19127430 CALL HANDLING SYSTEMS AND METHODS Telefonaktiebolaget Lm Ericsson (Publ) HUQ, FARZANA B 2455 §101§103 Non-Final OA — Pending May 06, 2025
19191890 LOW-SORBING GLYBURIDE FORMULATION AND METHODS Remedy Pharmaceuticals, Inc. THOMAS, TIMOTHY P 1614 §103 Final Rejection — Pending Apr 28, 2025
19123198 UPDATING A MAP FOR SIMULTANEOUS LOCALISATION AND MAPPING Telefonaktiebolaget Lm Ericsson (Publ) DUNNE, KENNETH MICHAEL 3669 §101§112 Non-Final OA — Pending Apr 22, 2025
19177910 METHODS OF AND DEVICES FOR IMPLEMENTING AND EXECUTING POLICY RULES ON A PER APPLICATION BASIS IN A TELECOMMUNICATIONS SYSTEM Telefonaktiebolaget Lm Ericsson (Publ) FANG, PAKEE 2409 §101§103 Final Rejection — Pending Apr 14, 2025
19173881 DECODING BASED ON BI-DIRECTIONAL PICTURE CONDITION Telefonaktiebolaget Lm Ericsson (Publ) TORRENTE, RICHARD T 2485 §102§103 Non-Final OA — Pending Apr 09, 2025
19119284 EXTENDER AND MODULAR SCREED RAIL SYSTEM Concrete Floor Products Limited CAJILIG, CHRISTINE T 3633 §102§103 Non-Final OA — Pending Apr 08, 2025
19171825 ADAPTIVE COMFORT NOISE PARAMETER DETERMINATION Telefonaktiebolaget Lm Ericsson (Publ) CRESPO FEBLES, HECTOR J 2658 §101§102Other Non-Final OA — Pending Apr 07, 2025
19093786 SYSTEMS, METHODS, AND COMPUTER PROGRAM PRODUCTS FOR INTEGRATING MENSTRUAL CYCLE DATA AND PROVIDING CUSTOMIZED FEMININE WELLNESS INFORMATION 28 Wellness, Inc. FRISBY, KESHA 3715 §101§102 Non-Final OA — Pending Mar 28, 2025
19089233 SUPPORT FOR GENERATION OF COMFORT NOISE, AND GENERATION OF COMFORT NOISE Telefonaktiebolaget Lm Ericsson (Publ) KRZYSTAN, ALEXANDER J 2694 §102§103Other Non-Final OA — Pending Mar 25, 2025
19083019 DATA SEQUENCE GENERATION Telefonaktiebolaget Lm Ericsson (Publ) MEI, XU 2695 DP Non-Final OA — Pending Mar 18, 2025
19111021 CARBON NANOTUBE DISPERSION AND METHOD FOR PREPARING THE SAME LG Chem, Ltd. NGUYEN, TRI V 1764 §103Other Non-Final OA — Pending Mar 12, 2025
19111208 MICROORGANISM SIMULTANEOUSLY PRODUCING 1,3-PROPANEDIOL AND 3-HYDROXYPROPIONIC ACID, AND USE THEREOF LG Chem, Ltd. GANGLE, BRIAN J 1645 §102§112 Non-Final OA — Pending Mar 12, 2025
19076845 PROVIDING SEGMENT PRESENCE INFORMATION Telefonaktiebolaget Lm Ericsson (Publ) VAZQUEZ COLON, MARIA E 2482 §102§103 Non-Final OA — Pending Mar 11, 2025
19074698 METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY Sunvax Mrna Therapeutics Inc. ZARA, JANE J 1637 §103§112 Non-Final OA — Pending Mar 10, 2025
19107388 BANDGAP REFERENCE VOLTAGE GENERATION CIRCUIT AND SEMICONDUCTOR DEVICE INCLUDING SAME LX SEMICON CO., LTD. CORDOVA RODRIGUEZ, ULARISLAO 2838 §103 Non-Final OA — Pending Feb 27, 2025
19043831 COSMETIC COMPOSITIONS FOR LIPS COMPRISING COLORANTS Amorepacific Corporation PRAGANI, RAJAN 1614 §103 Non-Final OA — Pending Feb 03, 2025
19043298 ON-DEVICE ARTIFICIAL INTELLIGENCE (AI) DEVICE OF PROVIDING MULTI-WAY INTERPRETATION SERVICE AND METHOD THEREOF LX SEMICON CO., LTD. SHARMA, NEERAJ 2659 §102§103 Non-Final OA — Pending Jan 31, 2025
19027065 METHODS AND DEVICES FOR VECTOR SEGMENTATION FOR CODING Telefonaktiebolaget Lm Ericsson (Publ) LELAND III, EDWIN S 2654 §101§112 Final Rejection — Pending Jan 17, 2025
18996000 POLY(LACTIC ACID-b-3-HYDROXYPROPIONIC ACID) BLOCK COPOLYMER COMPOSITION AND FILM COMPRISING THEREOF LG Chem, Ltd. ZHANG, MICHAEL N 1781 §101§103Other Non-Final OA — Pending Jan 17, 2025
19030365 METHODS AND SYSTEMS FOR CALCULATING ANALYTE LEVELS Senseonics, Incorporated TU, AURELIE H 3791 §103DP Non-Final OA — Pending Jan 17, 2025
18994220 DISPLAY DRIVE DEVICE AND DISPLAY DEVICE COMPRISING SAME LX SEMICON CO., LTD. EDWARDS, MARK 2624 §103§112 Non-Final OA — Pending Jan 14, 2025
18993119 RENDERING OF OCCLUDED AUDIO ELEMENTS Telefonaktiebolaget Lm Ericsson (Publ) SUTHERS, DOUGLAS JOHN 2695 §101§102§112 Non-Final OA — Pending Jan 10, 2025
18992781 RENDERING OF OCCLUDED AUDIO ELEMENTS Telefonaktiebolaget Lm Ericsson (Publ) GANMAVO, KUASSI A 2692 §102§103 Non-Final OA — Pending Jan 09, 2025
19007732 SOUNDING REFERENCE TRANSMISSION Telefonaktiebolaget Lm Ericsson (Publ) PUENTE, EVA YI ZHENG 2632 §101 Final Rejection — Pending Jan 02, 2025
18984051 Roflumilast Formulations with an Improved Pharmacokinetic Profile Arcutis Biotherapeutics, Inc. GEMBEH, SHIRLEY V Other Non-Final OA — Pending Dec 17, 2024
18875398 METHOD FOR PREDICTING DELIRIUM OCCURRENCE, AND DEVICE FOR PREDICTING DELIRIUM OCCURRENCE USING SAME Human Anti-Aging Standards Research Institute Co., Ltd. OGLES, MATTHEW ERIC 3791 §101§102§103 Non-Final OA — Pending Dec 16, 2024
18875647 TUBERCULOSIS VACCINE COMPOSITION CONTAINING IMMUNE-ACTIVE SITE FUSION PROTEIN Myco-Rapha Inc. HAUK TEODORO, PRICILA NMN 1645 §102§103DP Non-Final OA — Pending Dec 16, 2024
18970662 READY-TO-USE SODIUM BICARBONATE FORMULATIONS AND PRODUCTS Inforlife SA BROWE, DAVID 1617 §103§112 Non-Final OA — Pending Dec 05, 2024
18962371 STABLE FORMULATIONS OF SHR0302 Arcutis Biotherapeutics, Inc. BRAUN, MADELINE E 1624 §102§103§112DP Non-Final OA — Pending Nov 27, 2024
18867894 METHOD AND APPARATUS FOR PATH SELECTION Telefonaktiebolaget Lm Ericsson (Publ) PASIA, REDENTOR M 2413 §102§103 Non-Final OA — Pending Nov 21, 2024
18867298 RELIABILITY TESTING USING FUNCTIONAL DEVICES Octavo Systems LLC FORTICH, ALVARO E 2858 §102§103 Non-Final OA — Pending Nov 19, 2024
18867184 FIRST NODE, SECOND NODE AND METHODS PERFORMED THEREBY FOR HANDLING TRANSMISSION OF A FIRST SIGNAL Telefonaktiebolaget Lm Ericsson (Publ) HENSON, BRANDON JAMES 3648 §102§112 Non-Final OA — Pending Nov 19, 2024
18950331 USING AN UPLINK GRANT AS TRIGGER OF FIRST OR SECOND TYPE OF CQI REPORT Telefonaktiebolaget Lm Ericsson (Publ) SMARTH, GERALD A 2478 §102Other Non-Final OA — Pending Nov 18, 2024
18864806 PUSHCHAIR SYSTEM CONVERTIBLE INTO A BICYCLE SEAT Jean-Baptiste Barbaroux ENGLISH, PETER C 3993 §103§112 Non-Final OA — Pending Nov 11, 2024
18942389 PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST AND SOLVENTS CAPABLE OF DISSOLVING HIGH AMOUNTS OF THE DRUG Arcutis Biotherapeutics, Inc. ISMAIL, REHANA 1625 DP Non-Final OA — Pending Nov 09, 2024

View all 284 →

Managing Rothwell, Figg, Ernst and Manbeck, P.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Rothwell, Figg, Ernst and Manbeck, P.C.'s patent allowance rate?

82.9% of resolved applications prosecuted by Rothwell, Figg, Ernst and Manbeck, P.C. were allowed, across 14,002 applications in USPTO records.

How many office actions does Rothwell, Figg, Ernst and Manbeck, P.C. average before allowance?

3.43 office actions per allowed application on average.

How many pending office actions does Rothwell, Figg, Ernst and Manbeck, P.C. have?

284 pending office actions as of October 2026, for 97 clients, before 271 examiners in 178 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month